Literature DB >> 8466094

Efficacy of laser-acupuncture in the prevention of exercise-induced asthma.

A R Morton1, S M Fazio, D Miller.   

Abstract

Many asthmatic patients are reluctant to follow the medication schedule prescribed for them and turn to alternative treatment methods. The results of this study indicate that one such method, laser acupuncture, does not prevent exercise-induced asthma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466094

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  7 in total

Review 1.  Laser acupuncture: past, present, and future.

Authors:  Peter Whittaker
Journal:  Lasers Med Sci       Date:  2004       Impact factor: 3.161

2.  Laser acupuncture in children and adolescents with exercise induced asthma.

Authors:  W Gruber; E Eber; D Malle-Scheid; A Pfleger; E Weinhandl; L Dorfer; M S Zach
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

Review 3.  Exercise-induced asthma and anaphylaxis.

Authors:  D O Hough; K L Dec
Journal:  Sports Med       Date:  1994-09       Impact factor: 11.136

Review 4.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 5.  Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials.

Authors:  Karin Meissner; Hans Distel; Ulla Mitzdorf
Journal:  BMC Med       Date:  2007-03-19       Impact factor: 8.775

Review 6.  Methods of effective low-level laser therapy in the treatment of patients with bronchial asthma (literature review).

Authors:  Sergey Vladimirovich Moskvin; Aleksandr Agubechirovich Khadartsev
Journal:  Biomedicine (Taipei)       Date:  2020-03-28

Review 7.  Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects.

Authors:  Sigurlaug H Hafliðadóttir; Carsten B Juhl; Sabrina M Nielsen; Marius Henriksen; Ian A Harris; Henning Bliddal; Robin Christensen
Journal:  Trials       Date:  2021-07-26       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.